In acute myeloid leukemia, IL-8 and CXCR2 were found to be overexpressed in stem and progenitor cells, and targeting CXCR2 reduced the viability of leukemic stem cells [92]. The gene discussed is CXCR2; the disease is acute myeloid leukemia.